Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125663971 | 12566397 | 1 | I | 20160425 | 20160711 | 20160718 | 20160718 | EXP | US-PFIZER INC-2016340894 | PFIZER | 69.00 | YR | F | Y | 74.83000 | KG | 20160718 | CN | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125663971 | 12566397 | 1 | PS | CADUET | AMLODIPINE BESYLATEATORVASTATIN CALCIUM | 1 | Oral | 1 DF, DAILY (10MG/10) | 21540 | 1 | DF | FILM-COATED TABLET | |||||||
| 125663971 | 12566397 | 2 | SS | CADUET | AMLODIPINE BESYLATEATORVASTATIN CALCIUM | 1 | 21540 | FILM-COATED TABLET | |||||||||||
| 125663971 | 12566397 | 3 | SS | CELEBREX | CELECOXIB | 1 | Oral | 200 MG, DAILY | 20998 | 200 | MG | CAPSULE, HARD | |||||||
| 125663971 | 12566397 | 4 | SS | DETROL LA | TOLTERODINE TARTRATE | 1 | Oral | 4 MG, DAILY | 21228 | 4 | MG | MODIFIED-RELEASE CAPSULE, SOFT | |||||||
| 125663971 | 12566397 | 5 | C | AVAPRO | IRBESARTAN | 1 | Oral | 300 MG, ONE TABLET DAILY | 0 | 300 | MG | TABLET | |||||||
| 125663971 | 12566397 | 6 | C | ACETAMINOPHENHYDROCODONE BITARTRATE | ACETAMINOPHENHYDROCODONE BITARTRATE | 1 | Oral | 1 TABLET AS NEEDED (HYDROCODONE10 MG/ACETAMINOPHEN 325 T) EVERY HOURS | 0 | 1 | DF | TABLET |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125663971 | 12566397 | 1 | Hypertension |
| 125663971 | 12566397 | 2 | Blood cholesterol increased |
| 125663971 | 12566397 | 3 | Antiinflammatory therapy |
| 125663971 | 12566397 | 4 | Urinary incontinence |
| 125663971 | 12566397 | 5 | Hypertension |
| 125663971 | 12566397 | 6 | Pain |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125663971 | 12566397 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125663971 | 12566397 | Diplegia | |
| 125663971 | 12566397 | Gait disturbance | |
| 125663971 | 12566397 | Movement disorder | |
| 125663971 | 12566397 | Nerve injury | |
| 125663971 | 12566397 | Spinal cord disorder |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |